186 related articles for article (PubMed ID: 16158248)
1. Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer.
Wang L; Guan X; Gong W; Yao J; Peng Z; Wei D; Wu TT; Huang S; Xie K
Clin Exp Metastasis; 2005; 22(3):205-13. PubMed ID: 16158248
[TBL] [Abstract][Full Text] [Related]
2. Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer.
Wang L; Shi GG; Yao JC; Gong W; Wei D; Wu TT; Ajani JA; Huang S; Xie K
Gastric Cancer; 2005; 8(1):18-28. PubMed ID: 15747170
[TBL] [Abstract][Full Text] [Related]
3. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
[TBL] [Abstract][Full Text] [Related]
4. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
[TBL] [Abstract][Full Text] [Related]
5. A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer.
Jiang Y; Wang L; Gong W; Wei D; Le X; Yao J; Ajani J; Abbruzzese JL; Huang S; Xie K
Clin Exp Metastasis; 2004; 21(8):755-64. PubMed ID: 16035620
[TBL] [Abstract][Full Text] [Related]
6. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.
Yao JC; Wang L; Wei D; Gong W; Hassan M; Wu TT; Mansfield P; Ajani J; Xie K
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4109-17. PubMed ID: 15217947
[TBL] [Abstract][Full Text] [Related]
7. [Expression of transcription factor SP1, vascular endothelial growth factor and CD34 in serosa-infiltrating gastric cancer and their relationship with biological behavior and prognosis].
Wei YZ; Li CF; Xue YW
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):145-9. PubMed ID: 19296249
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor Sp1 expression in gastric cancer and its relationship to long-term prognosis.
Zhang J; Zhu ZG; Ji J; Yuan F; Yu YY; Liu BY; Lin YZ
World J Gastroenterol; 2005 Apr; 11(15):2213-7. PubMed ID: 15818728
[TBL] [Abstract][Full Text] [Related]
9. Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancer.
Gong W; Jiang Y; Wang L; Wei D; Yao J; Huang S; Fang S; Xie K
Clin Cancer Res; 2005 Aug; 11(16):5778-83. PubMed ID: 16115916
[TBL] [Abstract][Full Text] [Related]
10. [Expression of hepatocyte growth factor, transcription factor SP1, vascular endothelial growth factor and CD34 in serosa-infiltrative gastric cancer and their relations with defluxion of gastric cancer cell and prognosis].
Li CF; Wei YZ; Xue YW
Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):206-9. PubMed ID: 19563076
[TBL] [Abstract][Full Text] [Related]
11. [Transcription factor Sp1 expression in gastric cancer and its prognostic value].
Zhang J; Ji J; Yuan F; Chen J; Yan M; Yu YY; Liu BY; Yin HR; Lin YZ; Zhu ZG
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):531-3. PubMed ID: 16438849
[TBL] [Abstract][Full Text] [Related]
12. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
13. [Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis].
Wang LW; Li Q; Hua ZL; Zhou F; Keping X; Daoyan W; Yao J; Ajani J
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):107-11. PubMed ID: 17645844
[TBL] [Abstract][Full Text] [Related]
14. The effect of Vasohibin-1 expression and tumor-associated macrophages on the angiogenesis in vitro and in vivo.
Shen Z; Yan Y; Ye C; Wang B; Jiang K; Ye Y; Mustonen H; Puolakkainen P; Wang S
Tumour Biol; 2016 Jun; 37(6):7267-76. PubMed ID: 26666821
[TBL] [Abstract][Full Text] [Related]
15. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer.
Wang L; Wei D; Huang S; Peng Z; Le X; Wu TT; Yao J; Ajani J; Xie K
Clin Cancer Res; 2003 Dec; 9(17):6371-80. PubMed ID: 14695137
[TBL] [Abstract][Full Text] [Related]
17. JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer.
Chen Y; Huang Y; Huang Y; Xia X; Zhang J; Zhou Y; Tan Y; He S; Qiang F; Li A; Re OD; Li G; Zhou J
Carcinogenesis; 2014 Feb; 35(2):442-51. PubMed ID: 24072772
[TBL] [Abstract][Full Text] [Related]
18. MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1.
Zhou C; Ji J; Cai Q; Shi M; Chen X; Yu Y; Liu B; Zhu Z; Zhang J
Mol Cancer; 2013 Sep; 12(1):102. PubMed ID: 24010737
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.
Jia Z; Zhang J; Wei D; Wang L; Yuan P; Le X; Li Q; Yao J; Xie K
Cancer Res; 2007 May; 67(10):4878-85. PubMed ID: 17510417
[TBL] [Abstract][Full Text] [Related]
20. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
